Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ANGOANGIODYNAMICS INC

Nasdaq · CIK 0001275187
Filer categoryAccelerated filer
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end0531
XBRL facts525

Identity from submissions API

NameANGIODYNAMICS INC
CIK0001275187
TickersANGO
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC3841 Surgical & Medical Instruments & Apparatus
EIN113146460
LEI—
Fiscal year end0531
State of incorporationDE DE
Phone5187981215
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
14 PLAZA DRIVE
LATHAM
NY
12110
NY
Mailing address
14 PLAZA DRIVE
LATHAM
NY
12110
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1687 filing rows loaded from submissions recent; extra archives: CIK0001275187-submissions-001.json (687 filings, 2004-03-05 to 2011-09-06).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 8-K 8-K 5.02,5.07,9.01 0001140361-26-044750 000-50761 261570924 34 149878 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-008102 005-80098 261560625 34 12098
2026-11-04 4 FORM 4 0001140361-26-041989 10076
2026-11-04 3 FORM 3 0001140361-26-041987 11760
2026-10-30 4 FORM 4 0001140361-26-041309 7027
2026-10-29 144 xsl144X01/primary_doc.xml 0001950047-26-010465 000-50761 261501548 33 6770
2026-10-08 10-Q 10-Q 0001628280-26-065423 000-50761 261449157 34 5909771 1 1
2026-10-08 DEFA14A DEFA14A 0001140361-26-039093 000-50761 261448630 34 1796083
2026-10-08 DEF 14A DEF 14A 0001140361-26-039022 000-50761 261448360 34 7628445 1 1
2026-10-08 8-K 8-K 2.02,7.01,9.01 0001140361-26-039020 000-50761 261448302 34 2437811 1 1
2026-10-08 8-K 8-K 1.01,5.02,9.01 0001140361-26-039019 000-50761 261448301 34 381339 1 1
2026-09-29 10-K/A 10-K/A 0001140361-26-037995 000-50761 261423614 34 3260172 1 1
2026-09-29 10-K/A 10-K/A 0001140361-26-037943 000-50761 261419505 34 2213049 1 1
2026-07-31 4 FORM 4 0001140361-26-030514 4942
2026-07-30 144 xsl144X01/primary_doc.xml 0001950047-26-007444 000-50761 261224734 33 5500
2026-07-24 4 FORM 4 0001140361-26-029636 9143
2026-07-24 4 FORM 4 0001140361-26-029635 9170
2026-07-24 4 FORM 4 0001140361-26-029634 9120
2026-07-24 4 FORM 4 0001140361-26-029633 9196
2026-07-24 4 FORM 4 0001140361-26-029632 9131
2026-07-22 4 FORM 4 0001140361-26-029341 4682
2026-07-22 4 FORM 4 0001140361-26-029340 4668
2026-07-22 4 FORM 4 0001140361-26-029339 4524
2026-07-22 4 FORM 4 0001140361-26-029338 4654
2026-07-22 4 FORM 4 0001140361-26-029337 4626
2026-07-22 4 FORM 4 0001140361-26-029336 4626
2026-07-22 4 FORM 4 0001140361-26-029335 4657
2026-07-22 4 FORM 4 0001140361-26-029334 7677
2026-07-22 4 FORM 4 0001140361-26-029333 7704
2026-07-22 4 FORM 4 0001140361-26-029332 7731
2026-07-22 4 FORM 4 0001140361-26-029331 7691
2026-07-22 4 FORM 4 0001140361-26-029330 7668
2026-07-21 4 FORM 4 0001140361-26-029190 4649
2026-07-21 4 FORM 4 0001140361-26-029188 8090
2026-07-21 4 FORM 4 0001140361-26-029185 8115
2026-07-21 4 FORM 4 0001140361-26-029181 8142
2026-07-21 4 FORM 4 0001140361-26-029178 11573
2026-07-21 4 FORM 4 0001140361-26-029176 8101
2026-07-14 10-K 10-K 0001628280-26-048138 000-50761 261174154 34 20834857 1 1
2026-07-14 8-K 8-K 2.02,7.01,9.01 0001140361-26-028368 000-50761 261172537 34 5034163 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003460 005-80098 26987566 34 12195
2026-04-23 8-K 8-K 8.01 0001140361-26-016424 000-50761 26889469 34 151421 1 1
2026-04-02 10-Q 10-Q 0001628280-26-023008 000-50761 26832147 34 6689500 1 1
2026-04-02 8-K 8-K 2.02,7.01,9.01 0001140361-26-012891 000-50761 26830632 34 4443281 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000689 005-80098 26797823 34 7066
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-26-001036 005-80098 26635472 34 23602
2026-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085936-26-000009 005-80098 26616729 34 6528
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-26-000676 005-80098 26612843 34 7117
2026-02-03 8-K 8-K 5.02,9.01 0001140361-26-003518 000-50761 26594552 34 320769 1 1
2026-01-14 8-K 8-K 7.01,9.01 0001140361-26-001154 000-50761 26531470 34 3686474 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-002149 005-80098 26520017 34 18123
2026-01-06 10-Q 10-Q 0001275187-26-000003 000-50761 26511022 34 6567773 1 1
2026-01-06 8-K 8-K 2.02,7.01,9.01 0001140361-26-000341 000-50761 26509398 34 4492982 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005009 005-80098 251486129 34 12185
2025-11-12 8-K 8-K 5.07 0001140361-25-041542 000-50761 251468648 34 163824 1 1
2025-10-22 4 FORM 4 0001140361-25-038873 4741
2025-10-21 S-8 S-8 0001140361-25-038817 333-290994 251407279 33 269883 1 1
2025-10-14 4 FORM 4 0001140361-25-038018 4142
2025-10-09 4 FORM 4 0001140361-25-037836 4823
2025-10-02 10-Q 10-Q 0001628280-25-043689 000-50761 251369001 34 5878865 1 1
2025-10-02 8-K 8-K 2.02,7.01,9.01 0001140361-25-037060 000-50761 251367034 34 3237544 1 1
2025-09-25 DEFA14A DEFA14A 0001628280-25-042707 000-50761 251340584 34 447962
2025-09-25 DEF 14A DEF 14A 0001628280-25-042704 000-50761 251340577 34 4686942 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003571 005-80098 251222090 34 10623
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-004708 005-80098 251213581 34 23839
2025-07-22 4 xslF345X05/form4.xml 0001140361-25-026800 7924
2025-07-22 4 xslF345X05/form4.xml 0001140361-25-026799 6254
2025-07-22 4 xslF345X05/form4.xml 0001140361-25-026798 7976
2025-07-22 4 xslF345X05/form4.xml 0001140361-25-026797 9703
2025-07-22 4 xslF345X05/form4.xml 0001140361-25-026796 7938
2025-07-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-069616 005-80098 251140427 34 18017
2025-07-21 4 FORM 4 0001140361-25-026633 4547
2025-07-18 4 FORM 4 0001140361-25-026465 14332
2025-07-18 4 FORM 4 0001140361-25-026464 15010
2025-07-18 4 FORM 4 0001140361-25-026463 7530
2025-07-18 4 FORM 4 0001140361-25-026462 17530
2025-07-18 4 FORM 4 0001140361-25-026461 14167
2025-07-18 4 FORM 4 0001140361-25-026460 11420
2025-07-18 4 FORM 4 0001140361-25-026466 14162
2025-07-18 4 FORM 4 0001140361-25-026459 11888
2025-07-18 4 FORM 4 0001140361-25-026458 11246
2025-07-18 4 FORM 4 0001140361-25-026457 11899
2025-07-18 4 FORM 4 0001140361-25-026456 11078
2025-07-18 4 FORM 4 0001140361-25-026455 11360
2025-07-18 4 FORM 4 0001140361-25-026454 13769
2025-07-18 10-K 10-K 0001275187-25-000014 000-50761 251132941 34 11841835 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003037 005-80098 251130856 34 17545
2025-07-15 8-K 8-K 2.02,7.01,9.01 0001140361-25-025835 000-50761 251123069 34 5418256 1 1
2025-06-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-003553 005-80098 251032630 34 23050
2025-05-28 8-K 8-K 1.01,2.03,9.01 0001140361-25-020621 000-50761 25995315 34 1300017 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002197 005-80098 25951728 34 10429
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000552 005-80098 25844541 34 10709
2025-04-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-034682 005-80098 25836142 34 14846
2025-04-02 10-Q 10-Q 0001275187-25-000010 000-50761 25803459 34 7484720 1 1
2025-04-02 8-K 8-K 7.01,9.01 0001140361-25-011779 000-50761 25802437 34 6634090 1 1
2025-04-02 8-K 8-K 2.02,7.01,9.01 0001140361-25-011767 000-50761 25802159 34 5461559 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001085936-25-000014 005-80098 25620847 34 6673
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085936-25-000007 005-80098 25619380 34 6553
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001463 005-80098 25594538 34 11751
2025-01-17 4 FORM 4 0001140361-25-001388 4188
2025-01-16 8-K 8-K 7.01,9.01 0001140361-25-001285 000-50761 25535772 34 3421453 1 1
2025-01-16 144 xsl144X01/primary_doc.xml 0001972362-25-000024 000-50761 25535746 33 4155
2025-01-08 10-Q 10-Q 0001275187-25-000005 000-50761 25517875 34 7262267 1 1
2025-01-08 8-K 8-K 7.01,9.01 0001140361-25-000538 000-50761 25516607 34 4846812 1 1
2025-01-08 8-K 8-K 2.02,7.01,9.01 0001140361-25-000535 000-50761 25516562 34 5258458 1 1
2024-12-04 4 FORM 4 0001140361-24-048416 7037
2024-12-04 3 FORM 3 0001140361-24-048414 2735
2024-11-15 8-K 8-K 5.02,5.07,9.01 0001140361-24-047071 000-50761 241467817 34 179142 1 1
2024-11-08 SC 13G/A us03475v1017_110824.txt 0002012383-24-003394 005-80098 241439567 34 13688
2024-10-23 SC 13G/A us03475v1017_102324.txt 0002012383-24-001856 005-80098 241389845 34 13676
2024-10-10 4 FORM 4 0001140361-24-043263 5548
2024-10-08 4 FORM 4 0001140361-24-043173 4132
2024-10-08 4 FORM 4 0001140361-24-043157 4830
2024-10-03 10-Q 10-Q 0001628280-24-042176 000-50761 241352381 34 6267656 1 1
2024-10-03 8-K 8-K 2.02,7.01,9.01 0001140361-24-042652 000-50761 241349912 34 4337779 1 1
2024-09-26 DEFA14A DEFA14A 0001628280-24-041346 000-50761 241328299 34 394510
2024-09-26 DEF 14A DEF 14A 0001628280-24-041344 000-50761 241328293 34 4762349 1 1
2024-08-02 4 FORM 4 0001140361-24-035601 9012
2024-08-02 4 FORM 4 0001140361-24-035600 9065
2024-08-02 4 FORM 4 0001140361-24-035599 9020
2024-08-02 4 FORM 4 0001140361-24-035598 8998
2024-08-02 4 FORM 4 0001140361-24-035597 10676
2024-07-25 4 FORM 4 0001140361-24-034272 6271
2024-07-25 4 FORM 4 0001140361-24-034271 6285
2024-07-25 4 FORM 4 0001140361-24-034270 6336
2024-07-25 4 FORM 4 0001140361-24-034269 6293
2024-07-25 4 FORM 4 0001140361-24-034268 6238
2024-07-25 10-K 10-K 0001628280-24-032989 000-50761 241142226 34 12021962 1 1
2024-07-23 4 FORM 4 0001140361-24-033912 9887
2024-07-23 4 FORM 4 0001140361-24-033786 4559
2024-07-23 4 FORM 4 0001140361-24-033785 4564
2024-07-23 4 FORM 4 0001140361-24-033784 4603
2024-07-23 4 FORM 4 0001140361-24-033783 4545
2024-07-19 4 FORM 4 0001140361-24-033638 9851
2024-07-19 4 FORM 4 0001140361-24-033634 19039
2024-07-19 4 FORM 4 0001140361-24-033637 9837
2024-07-19 4 FORM 4 0001140361-24-033633 4554
2024-07-19 4 FORM 4 0001140361-24-033636 4530
2024-07-19 4 FORM 4 0001140361-24-033632 4397
2024-07-19 4 FORM 4 0001140361-24-033635 9904
2024-07-19 4 FORM 4 0001140361-24-033631 4527
2024-07-19 4 FORM 4 0001140361-24-033630 4499
2024-07-19 4 FORM 4 0001140361-24-033629 9803
2024-07-19 4 FORM 4 0001140361-24-033628 4540
2024-07-19 4 FORM 4 0001140361-24-033627 4498
2024-07-16 8-K 8-K 2.02,7.01,9.01 0001140361-24-033242 000-50761 241118585 34 6592449 1 1
2024-07-16 8-K 8-K 2.02,9.01 0001140361-24-033240 000-50761 241118582 34 1487052 1 1
2024-05-30 SC 13G ANGO_SC13G_May2024.htm 0001273087-24-000074 005-80098 241005699 34 81681
2024-04-09 10-Q 10-Q 0001628280-24-015487 000-50761 24833505 34 7517355 1 1
2024-04-08 4 FORM 4 0001140361-24-018620 4825
2024-04-04 8-K 8-K 2.02,7.01,9.01 0001140361-24-017807 000-50761 24821618 34 5635549 1 1
2024-04-01 8-K 8-K 1.01 0001140361-24-016977 000-50761 24810896 34 159877 1 1
2024-03-22 UPLOAD filename1.pdf 0000000000-24-003193 000-50761 39635
2024-03-06 CORRESP filename1.htm 0001140361-24-011791 196205
2024-03-04 4 FORM 4 0001140361-24-011190 4403
2024-02-22 UPLOAD filename1.pdf 0000000000-24-002014 000-50761 49160
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020288 005-80098 24627379 34 12990
2024-02-13 8-K 8-K 5.02 0001140361-24-007427 000-50761 24625779 34 159960 1 1
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0000354204-24-002930 005-80098 24612128 34 19412
2024-01-23 SC 13G/A ANGO_SC13GA1_2024.htm 0001273087-24-000023 005-80098 24552932 34 81692
2024-01-23 SC 13G/A us03475v1017_012324.txt 0001086364-24-001727 005-80098 24552768 34 13426
2024-01-22 SC 13G/A AngioDynamics_Inc.txt 0000093751-24-000065 005-80098 24548020 34 8400
2024-01-22 8-K 8-K 5.02 0001140361-24-002997 000-50761 24547083 34 157490 1 1
2024-01-11 8-K 8-K 7.01,9.01 0001140361-24-001849 000-50761 24527961 34 1338905 1 1
2024-01-08 10-Q 10-Q 0001628280-24-000857 000-50761 24520795 34 6434930 1 1
2024-01-05 8-K 8-K 2.02,5.02,7.01,9.01 0001140361-24-000830 000-50761 24514430 34 5230104 1 1
2023-11-16 8-K 8-K 5.02,5.07,9.01 0001140361-23-053522 000-50761 231412144 34 182317 1 1
2023-11-07 DEFA14A DEFA14A 0001140361-23-051734 000-50761 231381655 34 19857
2023-10-06 SC 13G/A us03475v1017_100523.txt 0001306550-23-010079 005-80098 231313925 34 13488
2023-10-05 10-Q 10-Q 0001628280-23-033979 000-50761 231312144 34 5453282 1 1
2023-10-04 8-K 8-K 2.02,7.01,9.01 0001140361-23-046804 000-50761 231306568 34 4050594 1 1
2023-09-28 DEFA14A DEFA14A 0001628280-23-033188 000-50761 231289045 34 430231
2023-09-28 DEF 14A DEF 14A 0001628280-23-033186 000-50761 231289016 34 26231710 1 1
2023-09-21 4/A xslF345X05/form4.xml 0001140361-23-044840 9252
2023-09-21 4/A xslF345X05/form4.xml 0001140361-23-044839 9270
2023-09-21 4/A xslF345X05/form4.xml 0001140361-23-044837 9285
2023-09-21 4/A xslF345X05/form4.xml 0001140361-23-044835 9282
2023-09-21 4/A xslF345X05/form4.xml 0001140361-23-044830 9346
2023-09-12 SC 13G ANGO_SC13G_Sept2023.htm 0001273087-23-000134 005-80098 231250343 34 81556
2023-08-03 10-K 10-K 0001628280-23-027335 000-50761 231141194 34 11712857 1 1
2023-07-26 4 xslF345X05/form4.xml 0001140361-23-036322 8939
2023-07-26 4 xslF345X05/form4.xml 0001140361-23-036321 8865
2023-07-26 4 xslF345X05/form4.xml 0001140361-23-036320 8877
2023-07-26 4 xslF345X05/form4.xml 0001140361-23-036319 8880
2023-07-26 4 xslF345X05/form4.xml 0001140361-23-036318 8844
2023-07-25 4 xslF345X05/form4.xml 0001140361-23-036121 6110
2023-07-25 4 xslF345X05/form4.xml 0001140361-23-036120 6205
2023-07-25 4 xslF345X05/form4.xml 0001140361-23-036119 6131
2023-07-25 4 xslF345X05/form4.xml 0001140361-23-036118 6146
2023-07-25 4 xslF345X05/form4.xml 0001140361-23-036117 6157
2023-07-25 4 xslF345X05/form4.xml 0001140361-23-036116 6143
2023-07-24 8-K 8-K 5.02,9.01 0001140361-23-035863 000-50761 231105193 34 193070 1 1
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035728 9656
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035726 9608
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035731 9630
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035727 9645
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035729 9706
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035725 4375
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035730 9642
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035724 4273
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035723 4403
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035722 4430
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035721 4374
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035720 4406
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035719 4416
2023-07-21 4 xslF345X05/form4.xml 0001140361-23-035701 4375
2023-07-21 3 xslF345X02/form3.xml 0001140361-23-035699 12382
2023-07-18 4 xslF345X05/form4.xml 0001140361-23-035087 6111
2023-07-18 4 xslF345X05/form4.xml 0001140361-23-035086 6205
2023-07-18 4 xslF345X05/form4.xml 0001140361-23-035085 6143
2023-07-18 4 xslF345X05/form4.xml 0001140361-23-035084 6146
2023-07-18 4 xslF345X05/form4.xml 0001140361-23-035083 6131
2023-07-12 8-K 8-K 2.02,7.01,9.01 0001140361-23-034123 000-50761 231083260 34 3912221 1 1
2023-07-05 SC 13G/A angiodynamics13ga6_06302023.htm 0001040188-23-000066 005-80098 231067112 34 44046
2023-06-14 8-K 8-K 1.01,1.02,2.01,9.01 0001140361-23-029854 000-50761 231014643 34 960903 1 1
2023-06-08 8-K 8-K 8.01,9.01 0001140361-23-028985 000-50761 231002797 34 249159 1 1
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028006 13460
2023-06-02 8-K 8-K 8.01 0001140361-23-027896 000-50761 23986723 34 164332 1 1
2023-04-17 8-K 8-K 7.01,9.01 0001140361-23-018553 000-50761 23822812 34 4673635 1 1
2023-03-31 10-Q 10-Q 0001628280-23-010093 000-50761 23786679 34 6444949 1 1
2023-03-30 8-K FORM 8-K 2.02,7.01,9.01 0000914121-23-000149 000-50761 23777160 34 2557384 1 1
2023-03-06 8-K FORM 8-K 7.01,9.01 0000914121-23-000145 000-50761 23707542 34 5131900 1 1
2023-02-27 8-K FORM 8-K 8.01 0000914121-23-000135 000-50761 23671863 34 160019 1 1
2023-02-10 SC 13G/A SEC SCHEDULE 13G 0000354204-23-001346 005-80098 23610670 34 19306
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015311 005-80098 23602426 34 12886
2023-02-07 4 FORM 4 0001567619-23-002005 4695
2023-02-07 4 FORM 4 0001567619-23-002003 4727
2023-02-06 SC 13G/A ANGO_SC13GA_2023.htm 0001273087-23-000081 005-80098 23590785 34 81513
2023-02-03 SC 13G/A AngioDynamics_Inc.txt 0000093751-23-000100 005-80098 23583923 34 8381
2023-02-01 4 FORM 4 0001567619-23-001649 4928
2023-01-31 SC 13G/A angiodynamics13ga5_123122.htm 0001040188-23-000007 005-80098 23570584 34 44126
2023-01-26 SC 13G/A us03475v1017_012623.txt 0001306550-23-004376 005-80098 23554590 34 13149
2023-01-20 SC 13G/A us03475v1017_011923.txt 0001306550-23-000496 005-80098 23539128 34 13125
2023-01-12 8-K FORM 8-K 7.01,9.01 0000914121-23-000011 000-50761 23524917 34 5500417 1 1
2023-01-06 S-8 REGISTRATION STATEMENT 0000914121-23-000005 333-269151 23515741 33 84760
2023-01-06 10-Q 10-Q 0001275187-23-000005 000-50761 23515694 34 6939801 1 1
2023-01-05 8-K FORM 8-K 2.02,7.01,9.01 0000914121-23-000003 000-50761 23509715 34 2536317 1 1
2022-12-15 SC 13G ANGO_SC13G.htm 0001273087-22-000121 005-80098 221465087 34 81457
2022-11-30 8-K 8-K 2.02,7.01,9.01 0001140361-22-043590 000-50761 221434283 34 2818975 1 1
2022-11-23 8-K 8-K 8.01 0001140361-22-042873 000-50761 221412378 34 163588 1 1
2022-11-04 8-K FORM 8K 5.02,5.07,9.01 0000914121-22-004127 000-50761 221362616 34 183517 1 1
2022-10-12 4 FORM 4 0001567619-22-018449 4346
2022-10-12 DEFA14A SCHEDULE 14A 0000914121-22-004108 000-50761 221306954 34 60427
2022-10-11 10-Q 10-Q 0001275187-22-000026 000-50761 221304345 34 6047194 1 1
2022-10-11 4 FORM 4 0001567619-22-018410 4955
2022-10-06 8-K FORM 8-K 8.01 0000914121-22-004106 000-50761 221298099 34 166218 1 1
2022-10-06 8-K FORM 8-K 2.02,7.01,9.01 0000914121-22-004104 000-50761 221297094 34 2351588 1 1
2022-09-22 DEFA14A DEFA14A 0001275187-22-000023 000-50761 221258140 34 409745
2022-09-22 DEF 14A DEF 14A 0001275187-22-000021 000-50761 221258134 34 2059296
2022-08-31 8-K CURRENT REPORT 1.01,1.02,2.03,9.01 0000914121-22-004083 000-50761 221218877 34 1495084 1 1
2022-08-10 8-K CURRENT REPORT 7.01,9.01 0000914121-22-004074 000-50761 221150409 34 6145766 1 1
2022-08-01 4 FORM 4 0001567619-22-014709 4937
2022-07-22 4 FORM 4 0001567619-22-014379 10091
2022-07-22 4 FORM 4 0001567619-22-014377 10069
2022-07-22 4 FORM 4 0001567619-22-014375 10091
2022-07-22 4 FORM 4 0001567619-22-014373 10056
2022-07-22 4 FORM 4 0001567619-22-014371 10085
2022-07-22 4 FORM 4 0001567619-22-014369 10081
2022-07-22 4 FORM 4 0001567619-22-014367 10057
2022-07-22 4 FORM 4 0001567619-22-014365 10072
2022-07-22 4 FORM 4 0001567619-22-014363 4714
2022-07-22 4 FORM 4 0001567619-22-014361 4724
2022-07-22 4 FORM 4 0001567619-22-014359 4711
2022-07-22 4 FORM 4 0001567619-22-014357 4580
2022-07-22 4 FORM 4 0001567619-22-014355 4683
2022-07-22 4 FORM 4 0001567619-22-014352 4738
2022-07-22 4 FORM 4 0001567619-22-014350 4682
2022-07-22 10-K 10-K 0001275187-22-000017 000-50761 221099754 34 12298015 1 1
2022-07-18 4 FORM 4 0001567619-22-014116 8262
2022-07-18 4 FORM 4 0001567619-22-014114 8394
2022-07-14 4 FORM 4 0001567619-22-014017 8280
2022-07-12 8-K CURRENT REPORT 2.02,7.01,9.01 0000914121-22-004052 000-50761 221078239 34 3314885 1 1
2022-07-11 4 FORM 4 0001567619-22-013850 9247
2022-07-11 4 FORM 4 0001567619-22-013848 9259
2022-07-11 4 FORM 4 0001567619-22-013846 9278
2022-07-11 4 FORM 4 0001567619-22-013844 9242
2022-07-11 4 FORM 4 0001567619-22-013842 9280
2022-05-02 4 FORM 4 0001567619-22-009209 4936
2022-04-21 4 FORM 4 0001567619-22-008816 6632
2022-04-13 4 FORM 4 0001567619-22-008484 6782
2022-04-07 10-Q 10-Q 0001275187-22-000010 000-50761 22814020 34 6635375 1 1
2022-04-07 8-K CURRENT REPORT 2.02,7.01,9.01 0000914121-22-002826 000-50761 22812291 34 2661667 1 1
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016487 005-80098 22606406 34 12881
2022-02-09 SC 13G/A ANGIODYNAMICS_INC.txt 0000093751-22-000018 005-80098 22605126 34 8341
2022-02-08 SC 13G/A SEC SCHEDULE 13G 0000354204-22-001496 005-80098 22601051 34 19306
2022-02-04 4 FORM 4 0001567619-22-002518 4698
2022-02-03 4 FORM 4 0001567619-22-002444 4727
2022-02-01 SC 13G/A angiodynamics13ga4_123121.htm 0001040188-22-000011 005-80098 22577433 34 44039
2022-01-28 SC 13G/A us03475v1017_012822.txt 0000834237-22-003212 005-80098 22567376 34 13073
2022-01-12 4 FORM 4 0001567619-22-001116 4348
2022-01-12 4 FORM 4 0001567619-22-001113 4956
2022-01-10 8-K FORM 8-K 7.01,9.01 0000914121-22-000132 000-50761 22519704 34 9717849 1 1
2022-01-07 10-Q 10-Q 0001275187-22-000005 000-50761 22517246 34 6476409 1 1
2022-01-06 8-K CURRENT REPORT 2.02,7.01,9.01 0000914121-22-000084 000-50761 22513622 34 2289701 1 1
2021-12-30 3 FORM 3 0001567619-21-022719 26811
2021-12-30 4/A FORM 4/A 0001567619-21-022716 5642
2021-12-30 4/A FORM 4/A 0001567619-21-022713 10866
2021-12-30 4/A FORM 4/A 0001567619-21-022711 8694
2021-12-30 4/A FORM 4/A 0001567619-21-022709 5654
2021-12-30 4/A FORM 4/A 0001567619-21-022707 5720
2021-12-30 4/A FORM 4/A 0001567619-21-022705 8702
2021-12-06 8-K CURRENT REPORT 8.01 0000914121-21-007590 000-50761 211472027 34 157380 1 1
2021-11-05 4 FORM 4 0001567619-21-019404 4726
2021-11-03 8-K CURRENT REPORT 5.07 0000914121-21-007073 000-50761 211375956 34 175956 1 1
2021-10-21 4 FORM 4 0001567619-21-018544 4919
2021-10-21 4 FORM 4 0001567619-21-018541 10487
2021-10-18 4 FORM 4 0001567619-21-018407 8648
2021-10-06 4 FORM 4 0001567619-21-017999 8633
2021-09-30 10-Q 10-Q 0001275187-21-000023 000-50761 211295479 34 5640698 1 1
2021-09-30 8-K CURRENT REPORT 2.02,7.01,9.01 0000914121-21-006377 000-50761 211293563 34 2098386 1 1
2021-09-22 DEFA14A DEFA14A 0001275187-21-000019 000-50761 211268897 34 798442
2021-09-22 DEF 14A DEF 14A 0001275187-21-000017 000-50761 211268879 34 1630454
2021-08-18 4/A FORM 4/A 0001567619-21-016025 9502
2021-08-18 4/A FORM 4/A 0001567619-21-016023 9533
2021-08-18 4/A FORM 4/A 0001567619-21-016021 9494
2021-08-18 4/A FORM 4/A 0001567619-21-016019 9493
2021-08-17 4 FORM 4 0001567619-21-015952 11046
2021-08-17 4 FORM 4 0001567619-21-015951 11091
2021-08-17 4 FORM 4 0001567619-21-015950 11059
2021-08-17 4 FORM 4 0001567619-21-015946 11055
2021-08-05 SC 13G/A angiodynamics13ga3_73121.htm 0001040188-21-000134 005-80098 211146846 34 44033
2021-07-30 4 FORM 4 0001567619-21-014233 8034
2021-07-30 4 FORM 4 0001567619-21-014231 7930
2021-07-27 4 FORM 4 0001567619-21-014064 4723
2021-07-27 4 FORM 4 0001567619-21-014063 4710
2021-07-27 4 FORM 4 0001567619-21-014062 4693
2021-07-27 4 FORM 4 0001567619-21-014055 4726
2021-07-27 3 FORM 3 0001567619-21-014053 16291
2021-07-27 10-K 10-K 0001275187-21-000013 000-50761 211117386 34 12292928 1 1
2021-07-23 4 FORM 4 0001567619-21-013937 4580
2021-07-23 4 FORM 4 0001567619-21-013935 12285
2021-07-23 4 FORM 4 0001567619-21-013933 12240
2021-07-23 4 FORM 4 0001567619-21-013931 4710
2021-07-23 4 FORM 4 0001567619-21-013929 15071
2021-07-23 4 FORM 4 0001567619-21-013927 12194
2021-07-23 4 FORM 4 0001567619-21-013925 15070
2021-07-23 4 FORM 4 0001567619-21-013923 22274
2021-07-23 4 FORM 4 0001567619-21-013921 12274
2021-07-23 4 FORM 4 0001567619-21-013920 22285
2021-07-23 4 FORM 4 0001567619-21-013917 22309
2021-07-23 4 FORM 4 0001567619-21-013915 12180
2021-07-23 4 FORM 4 0001567619-21-013914 9832
2021-07-13 8-K CURRENT REPORT 7.01,9.01 0000914121-21-004918 000-50761 211086869 34 12458787 1 1
2021-07-13 8-K CURRENT REPORT 2.02,7.01 0000914121-21-004916 000-50761 211086800 34 2467090 1 1
2021-05-25 8-K CURRENT REPORT 7.01,9.01 0000914121-21-003853 000-50761 21957320 34 5842704 1 1
2021-04-16 4 FORM 4 0001567619-21-008240 17414
2021-04-15 4 FORM 4 0001567619-21-008147 13128
2021-04-12 8-K FORM 8-K 7.01,9.01 0000914121-21-002530 000-50761 21819290 34 6086565 1 1
2021-04-05 4 FORM 4 0001567619-21-007649 17199
2021-03-31 10-Q 10-Q 0001275187-21-000008 000-50761 21791456 34 6908435 1 1
2021-03-30 8-K FORM 8-K 2.02,7.01,9.01 0000914121-21-001868 000-50761 21783605 34 2068541 1 1
2021-03-09 8-K CURRENT REPORT 7.01,9.01 0000914121-21-001492 000-50761 21724142 34 6570949 1 1
2021-02-12 SC 13G/A SEC SCHEDULE 13G 0000354204-21-000106 005-80098 21625981 34 19315
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-017443 005-80098 21610029 34 13751
2021-02-05 SC 13G AngioDynamics_Inc.txt 0000093751-21-000073 005-80098 21594601 34 8328
2021-02-04 4 FORM 4 0001567619-21-002187 4677
2021-02-03 4 FORM 4 0001567619-21-002156 7218
2021-02-03 3 FORM 3 0001567619-21-002153 2935
2021-02-03 8-K CURRENT REPORT 5.02,9.01 0000914121-21-000581 000-50761 21586537 34 506894 1 1
2021-02-02 SC 13G/A angiodynamics13ga2_123120.htm 0001040188-21-000013 005-80098 21579463 34 44217
2021-01-25 SC 13G us03475v1017_012521.txt 0000834237-21-000444 005-80098 21550256 34 13068
2021-01-21 4 FORM 4 0001567619-21-001303 4808
2021-01-19 S-8 REGISTRATION STATEMENT 0000914121-21-000170 333-252209 21535255 33 82456
2021-01-11 8-K CURRENT REPORT 7.01 0000914121-21-000070 000-50761 21520483 34 6243220 1 1
2021-01-08 10-Q 10-Q 0001275187-21-000005 000-50761 21516461 34 7077886 1 1
2021-01-07 8-K/A AMENDMENT NO. 1 TO THE FORM 8-K FILED JANUARY 7, 2021 7.01,9.01 0000914121-21-000060 000-50761 21514369 34 2777761 1 1
2021-01-07 8-K FORM 8-K 2.02,7.01,9.01 0000914121-21-000046 000-50761 21512981 34 3104142 1 1
2020-12-21 4 FORM 4 0001567619-20-021448 4702
2020-11-19 8-K FORM 8-K 7.01,9.01 0000914121-20-004172 000-50761 201327004 34 4401597 1 1
2020-11-03 4 FORM 4 0001567619-20-018615 4739
2020-10-15 8-K FORM 8-K 5.02,5.07,9.01 0000914121-20-003700 000-50761 201240331 34 190519 1 1
2020-10-07 10-Q 10-Q 0001275187-20-000034 000-50761 201229292 34 6528491 1 1
2020-09-29 8-K CURRENT REPORT 2.02,7.01,9.01 0000914121-20-003469 000-50761 201206002 34 2803770 1 1
2020-09-16 4 FORM 4 0001567619-20-016796 4717
2020-09-16 3 FORM 3 0001567619-20-016792 16711
2020-09-14 3 FORM 3 0001567619-20-016696 23239
2020-09-03 DEFA14A DEFA14A 0001275187-20-000030 000-50761 201158931 34 378881
2020-09-03 DEF 14A DEF 14A 0001275187-20-000028 000-50761 201158925 34 2104384
2020-08-14 8-K CURRENT REPORT 5.02 0000914121-20-002881 000-50761 201106621 34 162592 1 1
2020-08-12 4 FORM 4 0001567619-20-014905 4327
2020-08-10 10-K 10-K 0001275187-20-000024 000-50761 201087047 34 16549378 1 1
2020-08-03 4 FORM 4 0001567619-20-014068 4952
2020-07-28 4 FORM 4 0001567619-20-013828 6438
2020-07-28 4 FORM 4 0001567619-20-013825 6493
2020-07-28 4 FORM 4 0001567619-20-013822 6473
2020-07-21 4 FORM 4 0001567619-20-013548 8175
2020-07-21 4 FORM 4 0001567619-20-013547 8198
2020-07-21 4 FORM 4 0001567619-20-013546 6493
2020-07-21 4 FORM 4 0001567619-20-013545 8208
2020-07-17 4 FORM 4 0001567619-20-013440 9767
2020-07-17 4 FORM 4 0001567619-20-013439 9787
2020-07-17 4 FORM 4 0001567619-20-013438 9821
2020-07-17 4 FORM 4 0001567619-20-013437 9799
2020-07-16 4 FORM 4 0001567619-20-013373 4741
2020-07-16 4 FORM 4 0001567619-20-013371 4685
2020-07-16 4 FORM 4 0001567619-20-013369 4727
2020-07-16 4 FORM 4 0001567619-20-013367 4583
2020-07-16 4 FORM 4 0001567619-20-013365 4680
2020-07-16 4 FORM 4 0001567619-20-013363 4713
2020-07-16 4 FORM 4 0001567619-20-013361 4685

Latest XBRL company facts

One latest value per concept from companyfacts (525 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 42.05M 2026-10-07 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
dei EntityPublicFloat Entity Public Float USD 436.29M 2025-11-30 2026 FY 10-K/A 2026-09-29 0001140361-26-037943
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD -320.18M 2025-06-01 2026-05-31 DEF 14A 2026-10-08 0001140361-26-039022
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 7.35M 2025-06-01 2026-05-31 DEF 14A 2026-10-08 0001140361-26-039022
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.80M 2025-06-01 2026-05-31 DEF 14A 2026-10-08 0001140361-26-039022
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 56.54 2025-06-01 2026-05-31 DEF 14A 2026-10-08 0001140361-26-039022
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 13.69M 2025-06-01 2026-05-31 DEF 14A 2026-10-08 0001140361-26-039022
ecd PeoTotalCompAmt PeoTotalCompAmt USD 6.06M 2025-06-01 2026-05-31 DEF 14A 2026-10-08 0001140361-26-039022
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 49.65 2025-06-01 2026-05-31 DEF 14A 2026-10-08 0001140361-26-039022
invest DerivativeNotionalAmount Derivative, Notional Amount USD 100.00M 2013-09-19 2016 Q3 10-Q 2016-04-11 0001275187-16-000030
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 26.58M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 44.91M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 741,000 2013-11-30 2014 Q2 10-Q 2014-01-09 0001193125-14-006691
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 28.81M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 4.00M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 3.06M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap AccruedRentCurrent Accrued Rent, Current USD 29,000 2016-02-29 2016 Q3 10-Q 2016-04-11 0001275187-16-000030
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 1.45M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 69.67M 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 4.68M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 639.31M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.50M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 0 2014-06-01 2015-05-31 2015 FY 10-K 2015-08-10 0001275187-15-000018
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD -146,000 2013-06-01 2014-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4.50M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 3.64M 2013-06-01 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 1.74M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2013-06-01 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.73M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.62M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap Assets Assets USD 241.93M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AssetsCurrent Assets, Current USD 143.00M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2018-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 33,000 2018-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.35M 2018-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 0 2018-02-28 2018 Q3 10-Q 2018-04-05 0001275187-18-000007
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 69,000 2018-02-28 2018 Q3 10-Q 2018-04-05 0001275187-18-000007
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) USD 2.15M 2013-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 0 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 0 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.32M 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap AvailableforsaleSecuritiesFailedAuctionValue Available-for-sale Securities, Failed Auction, Value USD 1.30M 2018-08-31 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 15,000 2012-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 200,000 2012-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap BusinessAcquisitionContingentConsiderationAtFairValueCurrent Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) USD 12.70M 2013-08-31 2014 Q1 10-Q 2013-10-10 0001193125-13-396632
us-gaap BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) USD 67.10M 2013-08-31 2014 Q1 10-Q 2013-10-10 0001193125-13-396632
us-gaap BusinessAcquisitionCostOfAcquiredEntityCashPaid Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) USD 15.11B 2012-11-30 2013 Q2 10-Q 2013-01-09 0001193125-13-008058
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquired Business Acquisition, Purchase Price Allocation, Assets Acquired (Deprecated 2013-01-31) USD 379.65M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) USD 361.36M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) USD 7.68M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory Business Acquisition, Purchase Price Allocation, Current Assets, Inventory (Deprecated 2013-01-31) USD 26.85M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) USD 5.50M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables Business Acquisition, Purchase Price Allocation, Current Assets, Receivables (Deprecated 2013-01-31) USD 19.07M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationDeferredTaxAssetsNoncurrent Business Acquisition, Purchase Price Allocation, Deferred Tax Assets, Noncurrent (Deprecated 2013-01-31) USD 33.71M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillAmount Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) USD 145.22M 2012-05-22 2013 Q2 10-Q 2013-01-09 0001193125-13-008058
us-gaap BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill (Deprecated 2013-01-31) USD 107.10M 2012-05-22 2013 Q2 10-Q 2013-01-09 0001193125-13-008058
us-gaap BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed Business Acquisition, Purchase Price Allocation, Liabilities Assumed (Deprecated 2013-01-31) USD 18.29M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets (Deprecated 2013-01-31) USD 497,000 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment (Deprecated 2013-01-31) USD 34.02M 2012-05-22 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 33,000 2012-06-01 2013-02-28 2013 Q3 10-Q 2013-04-09 0001193125-13-147635
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2021-06-01 2022-05-31 2022 FY 10-K 2022-07-22 0001275187-22-000017
us-gaap BusinessCombinationContingentConsiderationAssetCurrent Business Combination, Contingent Consideration, Asset, Current USD 5.50M 2025-02-28 2025 Q3 10-Q 2025-04-02 0001275187-25-000010
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 27.29M 2020-02-29 2020 Q3 10-Q 2020-04-08 0001275187-20-000010
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2025-05-31 2025 FY 10-K 2025-07-18 0001275187-25-000014
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap BusinessDevelopment Business Development USD 5.40M 2013-12-04 2013-12-05 2014 Q3 10-Q 2014-04-09 0001193125-14-137100
us-gaap BusinessExitCosts Business Exit Costs (Deprecated 2013-01-31) USD 337,000 2012-06-01 2013-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap BusinessExitCosts1 Business Exit Costs USD 920,000 2012-12-01 2013-02-28 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 33.97M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -200.48M 2019-06-01 2020-02-29 2020 Q3 10-Q 2020-04-08 0001275187-20-000010
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 17.02M 2013-11-30 2014 Q2 10-Q 2014-01-09 0001193125-14-006691
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 33.97M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -19.89M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 75.00M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 43.04M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 42.42M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CommonStockValue Common Stock, Value, Issued USD 388,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -10.09M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ContractualObligation Contractual Obligation USD 5.70M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 40.10M 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 3.80M 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 3.22M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 3.22M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 3.22M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 3.22M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 343,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination USD 400,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 100,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 32.88M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 126.56M 2017-06-01 2018-02-28 2018 Q3 10-Q 2018-04-05 0001275187-18-000007
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 0 2017-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 186,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 299,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 113,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap CustomerRefundLiabilityCurrent Customer Refund Liability, Current USD 500,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 132.50M 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap DebtInstrumentInterestRateStatedPercentageRateRangeMinimum Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum (Deprecated 2016-01-31) pure 0.01 2012-06-01 2012-08-31 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 182,000 2023-05-31 2023 FY 10-K 2023-08-03 0001628280-23-027335
us-gaap DebtInstrumentUnamortizedDiscountPremiumNet Debt Instrument, Unamortized Discount (Premium), Net USD 593,000 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 158,000 2016-06-01 2016-11-30 2017 Q2 10-Q 2017-01-06 0001275187-17-000005
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 193,000 2023-02-28 2023 Q3 10-Q 2023-03-31 0001628280-23-010093
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 143,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent Deferred Income Taxes and Other Liabilities, Noncurrent USD 4.68M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent Deferred Income Taxes and Other Tax Liabilities, Noncurrent USD 5.32M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -306,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 12.07M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 35,000 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 0 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 36,000 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 72.33M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.30M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 18.39M 2015-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 21.70M 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 3.94M 2015-08-31 2016 Q1 10-Q 2015-10-08 0001275187-15-000022
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 0 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 46.34M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 0 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 7.85M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.90M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 11.90M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 65.49M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 5.23M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 71.80M 2017-05-31 2018 Q2 10-Q 2018-01-05 0001275187-18-000003
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 12.07M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 4.40M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DepositsAssets Deposits Assets USD 190,000 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap Depreciation Depreciation USD 10.50M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 5.50M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap DerivativeAssetNotionalAmount Derivative Asset, Notional Amount USD 100.00M 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap DerivativeFixedInterestRate Derivative, Fixed Interest Rate pure 0.007 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 873,000 2013-02-28 2013 Q3 10-Q 2013-04-09 0001193125-13-147635
us-gaap DerivativeSwaptionInterestRate Derivative, Swaption Interest Rate pure 0.033 2012-06-30 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 0 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 0 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap DisposalGroupIncludingDiscontinuedOperationDeferredRevenue Disposal Group, Including Discontinued Operation, Deferred Revenue USD 2.60M 2017-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent USD 25.98M 2023-05-31 2023 FY 10-K 2023-08-03 0001628280-23-027335
us-gaap DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent USD 17.63M 2023-05-31 2023 FY 10-K 2023-08-03 0001628280-23-027335
us-gaap DisposalGroupIncludingDiscontinuedOperationInventory1 Disposal Group, Including Discontinued Operation, Inventory USD 2.60M 2017-05-31 2017 FY 10-K 2017-08-04 0001275187-17-000026
us-gaap DisposalGroupIncludingDiscontinuedOperationInventoryCurrent Disposal Group, Including Discontinued Operation, Inventory, Current USD 4.15M 2023-05-31 2023 FY 10-K 2023-08-03 0001628280-23-027335
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current USD 2.00M 2023-05-31 2023 FY 10-K 2023-08-03 0001628280-23-027335
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent USD 44,000 2023-05-31 2023 FY 10-K 2023-08-03 0001628280-23-027335
us-gaap Dividends Dividends USD 0 2017-06-01 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.17 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.17 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.012 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.178 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 104,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.003 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.001 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.021 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.006 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.003 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.012 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount USD 0 2019-06-01 2020-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -354,000 2021-06-01 2021-11-30 2022 Q2 10-Q 2022-01-07 0001275187-22-000005
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -38,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 14.40M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 28.20M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 5.63M 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.70M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 3.20M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap EquityMethodInvestments Equity Method Investments USD 5.00M 2012-03-22 2013 Q2 10-Q 2013-01-09 0001193125-13-008058
us-gaap EscrowDeposit Escrow Deposit USD 2.50M 2012-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 0 2013-06-01 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 0 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap FairValueInputsCapRate Fair Value Inputs, Cap Rate (Deprecated 2018-01-31) pure 0.085 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.125 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) USD 8.40M 2019-03-01 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD 33,000 2018-06-01 2018-11-30 2019 Q2 10-Q 2019-01-07 0001275187-19-000009
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) USD 33,000 2018-06-01 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases USD 0 2018-06-01 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) USD 33,000 2018-06-01 2018-08-31 2019 Q1 10-Q 2018-10-01 0001275187-18-000020
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales USD 1.35M 2018-06-01 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2017-06-01 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 0 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 0 2018-06-01 2018-11-30 2019 Q2 10-Q 2019-01-07 0001275187-19-000009
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) USD 0 2018-06-01 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD 272,000 2024-06-01 2025-02-28 2025 Q3 10-Q 2025-04-02 0001275187-25-000010
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 272,000 2024-06-01 2025-05-31 2025 FY 10-K 2025-07-18 0001275187-25-000014
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) USD 0 2018-06-01 2018-08-31 2019 Q1 10-Q 2018-10-01 0001275187-18-000020
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales USD 0 2018-06-01 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD -9.75M 2017-06-01 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2025-05-31 2025 FY 10-K 2025-07-18 0001275187-25-000014
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 100,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 2.21M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 400,000 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 5.40M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 3.71M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 745,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 660,000 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 660,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 660,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 603,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1.50M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 99,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 140.92M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 17.38M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 10.86M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 8.18M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 5.31M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 5.00M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 10.75M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 10.76M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 202.81M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 61.89M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 0 2018-06-01 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2014-06-01 2015-05-31 2015 FY 10-K 2015-08-10 0001275187-15-000018
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 12.47M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap Goodwill Goodwill USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 11.43M 2019-06-01 2020-02-29 2020 Q3 10-Q 2020-04-08 0001275187-20-000010
us-gaap GoodwillAllocationAdjustment Goodwill, Allocation Adjustment (Deprecated 2013-01-31) USD -1.80M 2012-06-01 2013-02-28 2013 Q3 10-Q 2013-04-09 0001193125-13-147635
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 1.40M 2012-06-01 2013-02-28 2013 Q3 10-Q 2013-04-09 0001193125-13-147635
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 238,000 2023-06-01 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap GoodwillOtherIncreaseDecrease Goodwill, Other Increase (Decrease) USD -25.98M 2022-06-01 2023-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2017-06-01 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 500,000 2014-03-01 2014-05-31 2015 FY 10-K 2015-08-10 0001275187-15-000018
us-gaap GoodwillSubsequentRecognitionOfDeferredTaxAsset Goodwill, Subsequent Recognition of Deferred Tax Asset USD 779,000 2014-06-01 2015-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap GoodwillWrittenOffRelatedToSaleOfBusinessUnit Goodwill, Written off Related to Sale of Business Unit USD 75.31M 2018-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap GrossProfit Gross Profit USD 48.04M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 3.40M 2023-12-01 2024-02-29 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 1.30M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 81,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -31.55M 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -37.79M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -7.30M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 1.49M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -8.61M 2021-06-01 2021-08-31 2022 Q1 10-Q 2021-09-30 0001275187-21-000023
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.82 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.82 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap IncomeTaxesPaid Income Taxes Paid USD 102,000 2016-06-01 2017-05-31 2017 FY 10-K 2017-08-04 0001275187-17-000026
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 405,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -199,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 6.47M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2018-06-01 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap IncomeTaxReconciliationDeductionsQualifiedProductionActivities Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount USD 0 2013-06-01 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 16,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -7.62M 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 756,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 0 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 250,000 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 219,000 2016-06-01 2017-05-31 2017 FY 10-K 2017-08-04 0001275187-17-000026
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.32M 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 202,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -3,000 2016-06-01 2017-05-31 2017 FY 10-K 2017-08-04 0001275187-17-000026
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 90,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -422,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD 0 2013-06-01 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -17.42M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -3.47M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 0 2014-06-01 2015-05-31 2015 FY 10-K 2015-08-10 0001275187-15-000018
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 2.71M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.02M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Increase in Unrecognized Tax Benefits is Reasonably Possible USD 500,000 2023-05-31 2023 FY 10-K 2023-08-03 0001628280-23-027335
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 256.99M 2018-08-31 2019 Q1 10-Q 2018-10-01 0001275187-18-000020
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 61.89M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap InterestExpense Interest Expense USD -1.61M 2023-06-01 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -88,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 426,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap InterestReceivable Interest Receivable USD 1,000 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 25.42M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap InventoryNet Inventory, Net USD 54.95M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 24.42M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 6.40M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 5.11M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap InventoryWriteDown Inventory Write-down USD 2.90M 2023-12-01 2024-02-29 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 15,000 2016-06-01 2017-02-28 2017 Q3 10-Q 2017-04-03 0001275187-17-000008
us-gaap LandAndLandImprovements Land and Land Improvements USD 493,000 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.50M 2018-06-01 2019-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.61M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 171,000 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.61M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.15M 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 778,000 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 778,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.29M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.24M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 572,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap Liabilities Liabilities USD 77.97M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 241.93M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LiabilitiesCurrent Liabilities, Current USD 59.69M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap LineOfCredit Long-term Line of Credit USD 46.41M 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity USD 100.00M 2013-09-19 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap LitigationReserve Estimated Litigation Liability USD 12.50M 2017-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap LitigationSettlementAmount Litigation Settlement, Amount (Deprecated 2017-01-31) USD 74.90M 2014-03-17 2014-03-18 2017 Q3 10-Q 2017-04-03 0001275187-17-000008
us-gaap LoansPayable Loans Payable USD 25.00M 2022-05-31 2022 FY 10-K 2022-07-22 0001275187-22-000017
us-gaap LongTermDebt Long-term Debt USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2020-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 7.50M 2013-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 75.00M 2013-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 37.50M 2013-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 22.50M 2013-05-31 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 124.41M 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 61.41M 2014-11-30 2015 Q2 10-Q 2015-01-09 0001275187-15-000009
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 0 2024-02-29 2024 Q3 10-Q 2024-04-09 0001628280-24-015487
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 12.50M 2017-11-30 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap LossContingencyAccrualPayments Loss Contingency Accrual, Payments USD 12.70M 2018-07-01 2018-07-31 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 14.07M 2012-05-31 2012 FY 10-K 2012-08-14 0001193125-12-355457
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -1.38M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 41.17M 2018-06-01 2019-02-28 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -3.15M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -85.87M 2018-06-01 2019-02-28 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -15.33M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 12.43M 2018-06-01 2019-02-28 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7.10M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NoncashMergerRelatedCosts Noncash Merger Related Costs USD 0 2016-06-01 2016-08-31 2017 Q1 10-Q 2016-10-05 0001275187-16-000037
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD -11,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 117.93M 2011-06-01 2012-05-31 2012 FY 10-K 2012-08-14 0001193125-12-355457
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 0 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NotionalAmountOfInterestRateDerivatives Notional Amount of Interest Rate Derivatives (Deprecated 2013-01-31) USD 100.00M 2013-08-31 2014 Q1 10-Q 2013-10-10 0001193125-13-396632
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 2 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 2 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap NumberOfReportingUnits Number of Reporting Units reporting_unit 2 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap OciBeforeReclassificationsBeforeTaxAttributableToParent OCI, before Reclassifications, before Tax, Attributable to Parent USD -125,000 2018-06-01 2019-02-28 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap OperatingExpenses Operating Expenses USD 55.34M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -7.30M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 558,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.04M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.40M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.63M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingLeasePayments Operating Lease, Payments USD 403,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.92M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 12.75M 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.92M 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.13M 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.13M 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.34M 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 3.23M 2019-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.057 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.96M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 9.31M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherCommitment Other Commitment USD 667,000 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap OtherCommitmentDueAfterFifthYear Other Commitment, to be Paid, after Year Five USD 0 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap OtherCommitmentDueInFifthYear Other Commitment, to be Paid, Year Five USD 166,000 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap OtherCommitmentDueInFourthYear Other Commitment, to be Paid, Year Four USD 167,000 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap OtherCommitmentDueInSecondYear Other Commitment, to be Paid, Year Two USD 167,000 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap OtherCommitmentDueInThirdYear Other Commitment, to be Paid, Year Three USD 167,000 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -98,000 2011-06-01 2012-02-29 2012 Q3 10-Q 2012-04-09 0001193125-12-155135
us-gaap OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent USD -2.99M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD -2.99M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -140,000 2011-06-01 2012-05-31 2012 FY 10-K 2012-08-14 0001193125-12-355457
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -2.99M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.99M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax USD 0 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 0 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax USD 0 2017-06-01 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax USD 204,000 2011-06-01 2012-05-31 2012 FY 10-K 2012-08-14 0001193125-12-355457
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax USD 22,000 2011-06-01 2012-02-29 2012 Q3 10-Q 2012-04-09 0001193125-12-155135
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD 0 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -65,000 2011-06-01 2012-05-31 2012 FY 10-K 2012-08-14 0001193125-12-355457
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 27,000 2011-06-01 2012-02-29 2012 Q3 10-Q 2012-04-09 0001193125-12-155135
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 4.30M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 13.60M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 707,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 130,000 2019-06-01 2020-05-31 2020 FY 10-K 2020-08-10 0001275187-20-000024
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 94,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 3.58M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 100,000 2013-12-06 2014-02-28 2014 Q3 10-Q 2014-04-09 0001193125-14-137100
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 72,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap PaymentsForPreviousAcquisition Payments for Previous Acquisition USD 3.50M 2023-06-01 2023-08-31 2025 FY 10-K 2025-07-18 0001275187-25-000014
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2017-06-01 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD -801,000 2012-06-01 2013-02-28 2014 Q3 10-Q 2014-04-09 0001193125-14-137100
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 0 2016-06-01 2017-02-28 2017 Q3 10-Q 2017-04-03 0001275187-17-000008
us-gaap PaymentsForRestructuring Payments for Restructuring USD 2.62M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap PaymentsOfDividends Payments of Dividends USD 0 2013-06-01 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 3.25M 2023-06-01 2024-02-29 2024 Q3 10-Q 2024-04-09 0001628280-24-015487
us-gaap PaymentsToAcquireBusinessTwoNetOfCashAcquired Payments to Acquire Business Two, Net of Cash Acquired USD 0 2023-06-01 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap PaymentsToAcquireEquipmentOnLease Payments to Acquire Equipment on Lease USD 2.77M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 2.00M 2015-12-07 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2024-06-01 2025-02-28 2025 Q3 10-Q 2025-04-02 0001275187-25-000010
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 500,000 2011-06-01 2012-02-29 2012 Q3 10-Q 2012-04-09 0001193125-12-155135
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 379,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 9.17M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PrepaidInsurance Prepaid Insurance USD 395,000 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap PrepaidRent Prepaid Rent USD 225,000 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap PrepaidRoyalties Prepaid Royalties USD 521,000 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap PrepaidTaxes Prepaid Taxes USD 103,000 2018-02-28 2018 Q3 10-Q 2018-04-05 0001275187-18-000007
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 1.00M 2015-06-01 2016-05-31 2017 FY 10-K 2017-08-04 0001275187-17-000026
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates Proceeds from Divestiture of Businesses and Interests in Affiliates USD 0 2024-06-01 2025-02-28 2025 Q3 10-Q 2025-04-02 0001275187-25-000010
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2023-06-01 2024-02-29 2024 Q3 10-Q 2024-04-09 0001628280-24-015487
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 0 2024-06-01 2025-05-31 2025 FY 10-K 2025-07-18 0001275187-25-000014
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD -706,000 2019-06-01 2020-02-29 2020 Q3 10-Q 2020-04-08 0001275187-20-000010
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2023-06-01 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap ProceedsFromRepurchaseOfEquity Proceeds from (Repurchase of) Equity USD -2.10M 2011-06-01 2012-02-29 2013 Q3 10-Q 2013-04-09 0001193125-13-147635
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 1.00M 2011-06-01 2011-11-30 2012 Q2 10-Q 2012-01-05 0001193125-12-003595
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD -1.28M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 108.21M 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 27.73M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD -57,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap PurchaseObligation Purchase Obligation USD 2.95M 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap PurchaseObligationDueAfterFifthYear Purchase Obligation, to be Paid, after Year Five USD 0 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap PurchaseObligationDueInFifthYear Purchase Obligation, to be Paid, Year Five USD 0 2019-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap PurchaseObligationDueInFourthYear Purchase Obligation, to be Paid, Year Four USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 2.95M 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 0 2024-05-31 2024 FY 10-K 2024-07-25 0001628280-24-032989
us-gaap ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent USD 0 2018-06-01 2019-02-28 2019 Q3 10-Q 2019-04-02 0001275187-19-000014
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 7.98M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 37.00M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 1.00M 2013-12-06 2014-02-28 2014 Q3 10-Q 2014-04-09 0001193125-14-137100
us-gaap RestructuringCharges Restructuring Charges USD 617,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap RestructuringCosts Restructuring Costs USD 600,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap RestructuringReserve Restructuring Reserve USD 328,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap RestructuringReserveAcceleratedDepreciation Restructuring and Related Cost, Accelerated Depreciation USD 300,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD 0 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 1.84M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 337,000 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -473.04M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 80.92M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap Revenues Revenues USD 291.01M 2020-06-01 2021-05-31 2021 FY 10-K 2021-07-27 0001275187-21-000013
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 232,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 393,000 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 255.97M 2017-06-01 2018-02-28 2018 Q3 10-Q 2018-04-05 0001275187-18-000007
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 29.99M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap SeveranceCosts1 Severance Costs USD 1.10M 2014-06-01 2014-11-30 2015 Q2 10-Q 2015-01-09 0001275187-15-000009
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.50M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 160,845 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 15.39 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 259,917 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.47 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 549,777 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 14.62 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 112,396 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 13.81 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.52 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 14.20M 2020-11-30 2021 Q2 10-Q 2021-01-08 0001275187-21-000005
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.62M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.84M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.29 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 30,882 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 3.89M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.50M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 14.26 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 2.27M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 665,826 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 8.66 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 8.3 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 21.91 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 14.25 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 1.31M 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.28M 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 14.45 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit USD 0 2014-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap StandardProductWarrantyAccrual Standard Product Warranty Accrual USD 288,000 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 163.96M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 117.93M 2011-06-01 2012-05-31 2014 FY 10-K 2015-01-12 0001275187-15-000011
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 783,000 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1,000 2011-06-01 2011-11-30 2012 Q2 10-Q 2012-01-05 0001193125-12-003595
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD -478,000 2025-06-01 2025-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 248,000 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 2.10M 2011-06-01 2012-02-29 2012 Q3 10-Q 2012-04-09 0001193125-12-155135
us-gaap StockRepurchaseProgramAuthorizedAmount Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) USD 20.00M 2011-09-06 2011-10-05 2013 FY 10-K 2013-08-14 0001193125-13-334608
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 20.00M 2011-10-05 2015 FY 10-K 2015-08-10 0001275187-15-000018
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 3.40M 2023-12-01 2024-02-29 2025 FY 10-K 2025-07-18 0001275187-25-000014
us-gaap TaxBenefitFromStockOptionsExercised Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) USD -237,000 2011-06-01 2012-02-29 2012 Q3 10-Q 2012-04-09 0001193125-12-155135
us-gaap TaxBenefitFromStockOptionsExercised1 Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) USD -240,000 2011-06-01 2011-08-31 2013 Q1 10-Q/A 2012-11-09 0001193125-12-462191
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 118,000 2016-11-30 2017 Q2 10-Q 2017-01-06 0001275187-17-000005
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 613,847 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 7.38M 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap TreasuryStockRetiredParValueMethodAmount Treasury Stock, Retired, Par Value Method, Amount USD 0 2016-06-01 2017-05-31 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap TreasuryStockShares Treasury Stock, Shares shares 370,000 2022-11-30 2023 Q2 10-Q 2023-01-06 0001275187-23-000005
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 0 2014-06-01 2015-05-31 2015 FY 10-K 2015-08-10 0001275187-15-000018
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 642,305 2016-06-01 2017-02-28 2017 Q3 10-Q 2017-04-03 0001275187-17-000008
us-gaap TreasuryStockValue Treasury Stock, Value USD 7.38M 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 1.67M 2024-06-01 2025-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 3.80M 2019-02-28 2019 FY 10-K 2019-07-25 0001275187-19-000017
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2017-06-01 2018-05-31 2018 FY 10-K 2018-07-23 0001275187-18-000011
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2025-06-01 2026-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 100,000 2017-05-31 2017 FY 10-K 2017-08-04 0001275187-17-000026
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 40.40M 2015-06-01 2016-05-31 2017 FY 10-K 2017-08-04 0001275187-17-000026
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 46.58M 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 44.43M 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 2.69M 2015-06-01 2016-05-31 2016 FY 10-K 2016-08-01 0001275187-16-000034
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 42.02M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 42.02M 2026-06-01 2026-08-31 2027 Q1 10-Q 2026-10-08 0001628280-26-065423
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 900,000 2023-06-01 2024-05-31 2026 FY 10-K 2026-07-14 0001628280-26-048138

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →